We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-13.62%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$261B
AUM Growth
-$56.5B
Cap. Flow
-$9.3B
Cap. Flow %
-3.56%
Top 10 Hldgs %
16.51%
Holding
3,995
New
135
Increased
1,816
Reduced
1,720
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 18.75%
2 Financials 13.28%
3 Healthcare 12.15%
4 Consumer Discretionary 11.49%
5 Communication Services 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
3651
CALL
Target
TGT
$66.3B
$26K ﹤0.01%
+400
New +$30.8K
AAC
3652
DELISTED
AAC Holdings
AAC
$26K ﹤0.01%
18,897
-4,535
-19% -$18.2K
CARM
3653
DELISTED
Carisma Therapeutics
CARM
$25K ﹤0.01%
882
-27
-3% -$861
SN
3654
DELISTED
Sanchez Energy Corporation
SN
$25K ﹤0.01%
93,635
+1,900
+2% +$2.43K
DXLG icon
3655
Destination XL Group
DXLG
$32.9M
$24K ﹤0.01%
10,912
-325
-3% -$869
DMK
3656
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$24K ﹤0.01%
152
-13
-8% -$2.49K
CVRS
3657
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$24K ﹤0.01%
29,157
-258
-0.9% -$308
FSNN
3658
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$24K ﹤0.01%
14,527
-15,708
-52% -$35.4K
ARDX icon
3659
Ardelyx
ARDX
$1.24B
$21K ﹤0.01%
+11,554
New +$34K
DRRX
3660
DELISTED
DURECT Corp
DRRX
$21K ﹤0.01%
4,449
+44
+1% +$384
ROX
3661
DELISTED
Castle Brands, Inc.
ROX
$21K ﹤0.01%
24,531
-1,004
-4% -$924
LLEX
3662
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$21K ﹤0.01%
15,524
-1,311
-8% -$3.55K
SRRA
3663
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$20K ﹤0.01%
369
-469
-56% -$30K
EGY icon
3664
Vaalco Energy
EGY
$562M
$18K ﹤0.01%
12,554
-282
-2% -$539
STCN
3665
DELISTED
Steel Connect, Inc. Common Stock
STCN
$18K ﹤0.01%
1,104
-53
-5% -$907
AXAS
3666
DELISTED
Abraxas Petroleum Corp
AXAS
$18K ﹤0.01%
815
+277
+51% +$9.66K
ALSK
3667
DELISTED
Alaska Communications Systems
ALSK
$17K ﹤0.01%
11,601
-417
-3% -$635
AMR
3668
DELISTED
Alta Mesa Resources Inc
AMR
$17K ﹤0.01%
+17,414
New +$44.1K
QUIK icon
3669
QuickLogic
QUIK
$211M
$16K ﹤0.01%
1,549
-45
-3% -$580
VERU icon
3670
Veru
VERU
$35.5M
$16K ﹤0.01%
+1,120
New +$15.4K
ZOM
3671
DELISTED
Zomedica Corp.
ZOM
$16K ﹤0.01%
13,410
+899
+7% +$1.43K
MTNB icon
3672
Matinas BioPharma
MTNB
$1.91M
$15K ﹤0.01%
512
+64
+14% +$2.51K
INFI
3673
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$15K ﹤0.01%
12,955
-546
-4% -$982
AMPE
3674
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$15K ﹤0.01%
123
+1
+0.8% +$153
IMDZ
3675
DELISTED
Immune Design Corp.
IMDZ
$15K ﹤0.01%
11,306
+900
+9% +$1.56K

Similar funds

Invesco's Q4 2018 Portfolio in Review

As of Q4 2018, Invesco held 3,995 positions worth $261B, down 18% from $318B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Invesco withdrew a net $9.3B in Q4 2018, closing 180 positions and reducing 1,720 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $691M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Invesco opened a new position in Linde worth $106M.

  • Invesco's largest Q4 2018 buy was Linde: 679,076 shares worth $106M.
  • Invesco added most to NXP Semiconductors in Q4 2018, an estimated $253M increase.
  • Invesco's biggest Q4 2018 reduction was Apple, cutting an estimated $961M.
  • Invesco fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $691M.
  • Invesco's ten largest holdings make up 17% of its $261B portfolio in Q4 2018.
  • Invesco opened 135 new positions and closed 180 in Q4 2018.
  • Invesco's portfolio value fell 18% quarter-over-quarter to $261B.

Based on Invesco's 13F filing for Q4 2018, filed 14 Feb 2019.